A new Australian bio-technology company secures a licence to develop a drug to block the development of metastatic prostate cancer. Filamon Limited, an Australian drug development company focused on blocking the forces that turn cancer ...
An Australian biotech is hoping for success with its attempt to turn a virus into a cancer fighter after its first patient was dosed in a Los Angeles hospital last month. Imugene chief executive Leslie ...
ABA Legal Group is seeing significant growth in its Bioscience Unit as it plans to capitalise on renewed government and investor focus on Australia’s local life science and biotechnology industries. Driven by the impact of ...
Join our mailing list to be on the front lines of healthcare , get exclusive content, and promos.